<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">Chloroquine (CQ), a 4-aminoquinoline approved by the Food and Drug Administration to treat malaria, has long been prescribed prophylactically to pregnant women at risk of exposure to 
 <italic>Plasmodium</italic> parasites (
 <xref rid="bib23" ref-type="bibr">Levy et al., 1991</xref>). CQ reportedly exhibits antimalarial, anti-inflammatory, and antiviral activities, with 
 <italic>in vitro</italic> efficacy against several viruses, including CoVs (
 <xref rid="bib50" ref-type="bibr">Wilde De et al., 2014</xref>); however, real-time data concerning its 
 <italic>in vivo</italic> distribution during viral infection and anti-CoV activity in living animals remains limited.
</p>
